ELOVL2-AS1

Across TCGA pan-cancer cohorts, ELOVL2-AS1 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated ELOVL2-AS1 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher ELOVL2-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ELOVL2-AS1 expression acts as an unfavorable survival marker, although some lineages such as BRCA and UCS show a favorable association.

KIRP, UCEC, and BRCA are the cancer types where ELOVL2-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Tertile	All	0.825	0.947	<.001	114	view →
UCEC	DFS	Tertile	All	0.531	0.686	<.001	96	view →
BRCA	OS	Median	All	0.958	0.889	<.001	94	view →
UCS	OS	Tertile	II,III,IV	0.705	0.182	<.001	64	view →
CHOL	DFS	Tertile	III,IV	0.031	0.505	.003	51	view →
MESO	OS	Median	IV	0.822	0.339	.002	36	view →
HNSC	DFS	Quartile	IV	0.792	0.597	.001	30	view →
PAAD	DFS	Tertile	All	0.567	0.268	.003	30	view →
KIRC	DFS	Tertile	II,III,IV	0.302	0.637	.006	22	view →
THYM	DFS	Median	II,III,IV	0.952	0.643	.010	20	view →
LUSC	DFS	Median	All	0.798	0.720	.011	11	view →
READ	DFS	Tertile	II,III,IV	0.161	0.586	.049	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

ELOVL2-AS1–KIRP (DFS)

Open the KIRP breakdown →